Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.

Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.

Clinical illness with Plasmodium falciparum or Plasmodium vivax compromises the function of dendritic cells (DC) and expands regulatory T (Treg) cells. Individuals with asymptomatic parasitemia have clinical immunity, restricting parasite expansion and preventing clinical disease. The role of DC and...

Full description

Bibliographic Details
Main Authors:	Kho, S, Marfurt, J, Noviyanti, R, Kusuma, A, Piera, K, Burdam, F, Kenangalem, E, Lampah, D, Engwerda, C, Poespoprodjo, J, Price, R, Anstey, N, Minigo, G, Woodberry, T
Format:	Journal article
Language:	English
Published:	American Society for Microbiology 2015

Similar Items

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.
by: Kho, S, et al.
Published: (2016)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.
by: Kho, S, et al.
Published: (2016)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
by: Leonardo, L, et al.
Published: (2022)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
by: Leonardo, Leo, et al.
Published: (2022)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
by: Leo Leonardo, et al.
Published: (2022-09-01)

Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life.
by: Burdam, F, et al.
Published: (2016)

Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life.
by: Faustina Helena Burdam, et al.
Published: (2016-01-01)

Plasmodium falciparum activates CD16+ dendritic cells to produce TNF and IL-10 in subpatent malaria
by: Loughland, JR, et al.
Published: (2018)

Genetic micro-epidemiology of malaria in Papua Indonesia: Extensive P. vivax diversity and a distinct subpopulation of asymptomatic P. falciparum infections
by: Pava, Z, et al.
Published: (2017)

Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.
by: Salwati, E, et al.
Published: (2011)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
by: Poespoprodjo, JR, et al.
Published: (2014)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
by: Jeanne Rini Poespoprodjo, et al.
Published: (2014-01-01)

In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
by: Price, R, et al.
Published: (2010)

Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses.
by: Woodberry, T, et al.
Published: (2008)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
by: Pava, Z, et al.
Published: (2020)

Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia
by: Pava, Z, et al.
Published: (2016)

Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria.
by: Minigo, G, et al.
Published: (2009)

Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia
by: Oyong, DA, et al.
Published: (2018)

Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
by: Poespoprodjo, JR, et al.
Published: (2008)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia.
by: Zuleima Pava, et al.
Published: (2020-05-01)

Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
by: Wirjanata, G, et al.
Published: (2015)

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.
by: Yeo, T, et al.
Published: (2010)

Therapeutic response to Dihydroartemisinin-Piperaquine for P. falciparum and P. vivax nine years after its introduction in Southern Papua, Indonesia
by: Poespoprodjo, JR, et al.
Published: (2018)

Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
by: Marfurt, J, et al.
Published: (2011)

Reduced circulating dendritic cells in acute Plasmodium knowlesi and Plasmodium falciparum malaria despite elevated plasma Flt3 ligand levels
by: Jessica R. Loughland, et al.
Published: (2021-02-01)

Severe disease associated with both Plasmodium falciparum and P-vivax infection in Papua, Indonesia
by: Tjitra, E, et al.
Published: (2007)

Plasmodium falciparum and P. vivax demonstrate contrasting chloroquine resistance reversal phenotypes
by: Wirjanata, G, et al.
Published: (2017)

Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia.
by: Zuleima Pava, et al.
Published: (2016-01-01)

Acute malaria induced antibodies against merozoite surface protein 5: frequent induction and analysis of cross-reactivity between P-falciparum and P-vivax.
by: Woodberry, T, et al.
Published: (2008)

Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
by: Marfurt, J, et al.
Published: (2012)

Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
by: Marfurt, J, et al.
Published: (2011)

Potent ex vivo activity of naphthoquine and methylene blue against drug-resistant clinical isolates of Plasmodium falciparum and Plasmodium vivax
by: Wirjanata, G, et al.
Published: (2015)

Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria.
by: Gabriela Minigo, et al.
Published: (2009-04-01)

Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy study
by: Kho, S, et al.
Published: (2021)

Transcriptional profiling and immunophenotyping show sustained activation of blood monocytes in subpatent Plasmodium falciparum infection
by: Loughland, JR, et al.
Published: (2020)

Circulating neutrophil extracellular traps and neutrophil activation are increased in proportion to disease severity in human malaria
by: Kho, S, et al.
Published: (2018)

Vivax malaria: a major cause of morbidity in early infancy.
by: Poespoprodjo, JR, et al.
Published: (2009)

MULTIDRUG RESISTANT VIVAX MALARIA: A MAJOR CAUSE OF MORBIDITY IN EARLY LIFE
by: Poespoprodjo, JR, et al.
Published: (2008)

Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy study.
by: Steven Kho, et al.
Published: (2021-05-01)

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.
by: Douglas, N, et al.
Published: (2014)